BIH Lecture "Novel Approaches To Targeting Hematopoietic Stem Cells for Ex Vivo and in Vivo Gene Therapy" by Prof. Hans-Peter Kiem
The lecture will be moderated by Prof. Christopher Baum (Chairman of the BIH Board of Directors and Chief Translational Research Officer of Charité) Part of the Lecture Series "Frontiers in Translational Medicine - Scientific and Structural Challenges" on key questions of translation in medicine.
BIH Lecture
Novel Approaches To Targeting Hematopoietic Stem Cells for Ex Vivo and in Vivo Gene Therapy
Despite tremendous progress in the hematopoietic stem cell (HSC) gene therapy and gene editing field, there are a number of significant limitations to the availability and accessibility of these therapies. In my presentation, I will discuss how we can better target a more refined HSC population to significantly reduce the amounts of lentiviral vectors or gene editing reagents needed for the genetic engineering of HSCs. I will also discuss how we can make these therapies more portable and accessible by developing in vivo gene therapy approaches that would not require rare and highly sophisticated cell manufacturing facilities and thus could be more accessible and also available for patients in low and middle-income settings.
About the Speaker
Kiem is a world-renowned expert in stem cell gene therapy. His lab has developed gene therapy trials for Fanconi anemia, glioblastoma, and HIV. A major recent focus has been the development of in vivo gene therapy approaches using various delivery platforms including viral vectors and nanoformulations. He has had continuous NIH funding for the past 25 years and has published more than 300 manuscripts. Kiem was the inaugural recipient of the José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research at the Fred Hutch from 2009 to 2014 and now holds the Stephanus Family Endowed Chair for Cell and Gene Therapy and is Director of the Stem Cell and Gene Therapy Program at Fred Hutch. In May of 2022 he assumed his role as president of the American Society of Gene and Cell Therapy.
Registration
The lecture will be held online via GoToMeeting. To participate in the lecture, please register here.
The registration will be open until maximal participant capacity is reached.
Login Information
Login Information
Login via GoToMeeting
Please note that the login link and access code are not sent out immediately after your registration! You will receive both the evening before the event. You have the following possibilities to participate:- You can download the GoToMeeting App beforehand (please do so before the lecture starts!)
- You can link in via the Browser (preferably Chrome)
- You can dial in by telephone (you will receive the dial-in number after your registration)
For security reasons, please login to GoToMeeting with your full name and institution (preferably in abbreviated form). In order to save online capacity and to keep the transmission stable, we kindly ask you to turn off your camera and microphone immediately after joining the session and during the lecture.
Discussion via Chat Room
The discussion will be held via the Chat Room function of GoToMeeting. If you would like to join the discussion, please type in your question into the chat area and moderators will pose the question to the speaker or arrange a dialogue if applicable.
Recording
The BIH Lecture will be recorded for the documentation on our website. If you do not wish to be recorded, please make sure your camera and microphone are turned off at any time.
Thank you for your cooperation!
Info
When
September 16, 2022
12:00 - 1:00 pm
1:10 - 2:00 pm Meet the Speaker-Session
How
online via GoToMeeting
The login data will be provided shortly before the event.
Registration
Please register here.
Registration is open until the maximum number of participants is reached.
